Company

Novartis Terminates BrainTransporter Collaboration with BioArctic – Program Discontinued, $30 Million Upfront Retained in Full
BioArcticNovartis

Novartis Terminates BrainTransporter Collaboration with BioArctic – Program Discontinued, $30 Million Upfront Retained in Full

BioArctic AB (OTCMKTS: BRCTF) announced that Novartis AG (NYSE: NVS) has notified the company of its decision to terminate the Option, Collaboration and License Agreement entered into in August 2025.…

Jinhai Medical Signs Strategic Cooperation MOU with Digital Health China – Exploring Business Operations Collaboration and Equity Investment in Medical AI

Jinhai Medical Signs Strategic Cooperation MOU with Digital Health China – Exploring Business Operations Collaboration and Equity Investment in Medical AI

Fresenius Medical Care Inks Decade‑Long Biosimilar Partnership with WuXi Biologics – Rights to Up to 37 Candidates in Industry's Largest Deal of Its Kind

Fresenius Medical Care Inks Decade‑Long Biosimilar Partnership with WuXi Biologics – Rights to Up to 37 Candidates in Industry’s Largest Deal of Its Kind

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Sanofi's Gene Therapy SAR446597 Secures FDA Fast Track for Geographic Atrophy
NASDAQ: SNYOphthalmology

Sanofi’s Gene Therapy SAR446597 Secures FDA Fast Track for Geographic Atrophy

Tcelltech Secures USD 40 Million Series B Funding for TX-103 CAR-T Therapy Development
FinanceTcelltech

Tcelltech Secures USD 40 Million Series B Funding for TX-103 CAR-T Therapy Development

Hengrui Pharma and Kailera Announce Positive Phase III Results for HRS9531 in Obesity Treatment
Clinical trial resultsHengrui Pharmaceuticals

Hengrui Pharma and Kailera Announce Positive Phase III Results for HRS9531 in Obesity Treatment

Haisco Pharma Receives FDA Approval for Clinical Trials of Autoimmune Drug HSK47388
Auto-immuneClinical trial approval / initiation

Haisco Pharma Receives FDA Approval for Clinical Trials of Autoimmune Drug HSK47388

Show More